Edward Nirenberg on Nostr: Okay now my favorite part: the data on the effectiveness of nirsevimab (a ...
Published at
2024-06-28 15:19:05Event JSON
{
"id": "014e624e5f8af4557cc412657acc7e8ec477c2c716a7b5a850d09b89a3a53bd7",
"pubkey": "c67b38e4c5023e985f04ae7ab6a6669cf463220e1b9ed54b897d1957004603a4",
"created_at": 1719587945,
"kind": 1,
"tags": [
[
"proxy",
"https://med-mastodon.com/users/enirenberg/statuses/112694915615569427",
"activitypub"
]
],
"content": "Okay now my favorite part: the data on the effectiveness of nirsevimab (a long-lasting RSV monoclonal antibody) in babies: https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2024-06-26-28/04-RSV-Mat-Peds-Payne-508.pdf\n\nIt is FANTASTIC news.\n\nhttps://cdn.masto.host/medmastodoncom/media_attachments/files/112/694/915/494/336/308/original/04548fdfb44eb586.png",
"sig": "1c609ee722147bdc5741b880b7520efed2051cf0660994271661a4a689c6cbaa437e780438064a84b1745bad020d76908d7ec92b367fda91e954ffc54eca7d2b"
}
